EVOKE PHARMA, INC. Proceeds from Bank Debt
EVOKE PHARMA, INC. reported Proceeds from Bank Debt of $5.50 million for the 86-month period ending 2014-03-31, per its 10-Q filed 2014-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromBankDebt · last filed 2014-11-13
- EVOKE PHARMA, INC. proceeds from bank debt for the quarter ending 2013-12-31 was $0.00.
- EVOKE PHARMA, INC. proceeds from bank debt for the quarter ending 2013-09-30 was $0.00.
- EVOKE PHARMA, INC. proceeds from bank debt for the quarter ending 2013-06-30 was $0.00.
- EVOKE PHARMA, INC. proceeds from bank debt for the quarter ending 2013-03-31 was $2.00M.
- EVOKE PHARMA, INC. proceeds from bank debt for fiscal 2013 was $2.00M, a 100.00% increase from fiscal 2012.
- EVOKE PHARMA, INC. proceeds from bank debt for fiscal 2012 was $1.00M.
| Period end | Proceeds from Bank Debt 3 month | Proceeds from Bank Debt 6 month | Proceeds from Bank Debt 9 month | Proceeds from Bank Debt 12 month | Proceeds from Bank Debt 80 month | Proceeds from Bank Debt 83 month | Proceeds from Bank Debt 86 month |
|---|---|---|---|---|---|---|---|
| 2014-03-31 | $5.50M 10-Q · filed 2014-05-13 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 derived: sum of 3 quarters · filed 2014-11-13 | $2.00M 10-K · filed 2014-03-25 | $5.50M 10-K · filed 2014-03-25 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $2.00M 10-Q · filed 2014-11-13 | $2.00M derived: sum of 4 quarters · filed 2014-11-13 | $5.50M 10-Q · filed 2013-11-13 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $2.00M 10-Q · filed 2014-08-13 | $2.00M derived: sum of 3 quarters · filed 2014-08-13 | ||||
| 2013-03-31 | $2.00M 10-Q · filed 2014-05-13 | $2.00M derived: sum of 2 quarters · filed 2014-05-13 | |||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | $1.00M 10-K · filed 2014-03-25 | |||||
| 2012-09-30 | $1.00M 10-Q · filed 2013-11-13 |